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Summary
Osteopetrotic (op/op) mice have a severe deficiency of osteoclasts, monocytes, and peritoneal
macrophages because of a defect in the production of functional macrophage colony-stimulating
factor (M-CSF) resulting from a mutation within the M-CSF gene. In this study, we examined
whether daily 5-,uginjections of purified recombinant human M-CSF (rhM-CSF) for 14 d would cure
these deficiencies in the mutant mice. Monocytes in the peripheral blood of the oplop mice were
significantly increased in number after subcutaneous injections of the factor two or three times
a day. In contrast, osteopetrosis in the long bones of op/op mice was completely cured by only
one injection of rhM-CSF per day. Bone trabeculae in the diaphyses were removed. Many osteoclasts
were detected on the surface of bone trabeculae in the metaphyses. Although development of
toothgerms ofuninjected oplop mice was impaired, rhM-CSF injection restored the development
ofmolar tooth germs and led to tooth eruption as a consequence ofthe recovery ofbone-resorbing
activity. These results demonstrate that M-CSF is one ofthe factors responsible for the differentiation
of osteoclasts and monocyte/macrophages under physiological conditions.
M
ice homozygous for the recessive osteopetrosis muta-
tion (op/op) have a severe deficiency of osteoclasts,
monocytes, and peritoneal macrophages (1-3). These defects
of the oplop mice can be neither transferred into irradiated
normal mice (3), nor cured by transplants of normal spleen
or bone marrow cells (4). Recently, oplop mice have been
reported to have a defect in the productionoffunctional mac-
rophage colony-stimulating factor (M-CSF) (5-7), and Yoshida
et al. (5) found that the mutant mice have a 1-bp insertion
within the coding region of the M-CSF gene on chromo-
some 3. Furthermore, Wiktor-jedrzejczak et al. (6) found
that the macrophage deficiency in the peritoneal cavity of
oplop mice is partially corrected by implantation of diffusion
chambers containing M-CSF-producing L-929 cells. These
findings strongly suggest that lack of functional M-CSF is
the primary cause of the deficiency of monocyte/macrophages
and osteoclasts in the op/op mice.
However, the role of M-CSF in osteoclast differentiation
has been controversial. Although M-CSF has been reported
to stimulate osteoclast formation in vitro (8, 9), other reports
have been contradictory (10-13). Therefore, we examined
whether the osteoclastdeficiency in oplop mice couldbe cured
by an exogenous supply of purified human recombinant
M-CSF (rhM-CSF). We found that this deficiency, as well
as that ofmonocytes in the peripheral blood, was completely
cured by daily injections of the rhM-CSF for 14 d.
Materials and Methods
Mice.
￿
FZ hybrid mice of + / + , opl + , and oplop genotypes
were raised in our laboratory from breeding pairs of B6C3F1-a/a,
opl + mice obtained from The Jackson Laboratory, Bar Harbor,
ME. The mutant oplop mice could be clearly recognized by 10 d
of age by failure of eruption of the incisors and by a domed skull.
Injection of Hemopoietic Factors into oplop Mice.
￿
Purified rhM-
CSF was generously provided by Morinaga Milk Industry Co. Ltd.
(Kanagawa, Japan). 5 tog ofrhM-CSF was subcutaneously injected
one to three times a day into oplop mice that were 11 d old at the
start of the treatment. After consecutive injections of the factor
for 14 d, the mice were killed at 25 d of age.
Hematological Measurements.
￿
Peripheral blood of the mice was
obtained by retroorbital puncture under anesthesia. Nucleated cells
were counted in a hemocytometer. Cellularity of the spleen was
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Differential cell counts were performed on May-Griinwald/Giemsa-
stained smears, and the results were confirmed by staining for
nonspecific esterase.
Morphological Obsenaations.
￿
Tibias, femurs, and mandibles were
fixedin a mixture of 2% paraformaldehyde and 2% glutaraldehyde
in 0.1 M cacodylate buffer (pH 7.4) for 2 h at 4°C. After having
been rinsed in the buffer, some specimens were dehydrated in eth-
anol and embedded in JB-4 medium. 4-um-thick sections were
stained with toluidine blue or for tartrate-resistant acid phospha-
tase (TRACP) activity (14). Other specimens were decalcified in
5% EDTA (pH 7.2), post-fixed in 1% osmic acid, and embedded
in Epon 812. Ultrathin sections were stained and observed under
the electron microscope. Whole calvariae were fixed in 10%
phosphate-buffered formalin for 30 min at room temperature and
stained for TRACP activity.
Results and Discussion
After consecutive injections of purified rhM-CSF into oplop
mice, we compared their hematological profile with that of
uninjected littermates (age matched). As shown in Table 1,
we couldnot find monocytes in the peripheral blood of unin-
jected oplop mice by counting 200 nucleated cells. The number
of monocytes in the peripheral blood ofthe mutant mice was
increased by injections ofrhM-CSF two or three times a day
for 14 d, but not by a single daily injection, and the mono-
cyte counts were significantly higher than those in pheno-
typically normal + /? mice (Table 1). Monocyte counts in
spleens were not significantly different in any of the mice
(Table 2). A significant number of erythroblasts was detected
in the peripheral blood of uninjected op/op mutants, and the
erythroblast number decreased after the rhM-CSF injections
(Table 1). This increase in erythroblast number in the unin-
jected mutants seems to reflect the extramedullary hemopoi-
esis that occurs in these animals, as well as the drop in this
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number after the rhM-CSF treatment and the recovery of
bone marrow hemopoiesis (see below). These results dem-
onstrate that injection ofpurified rhM-CSF is enough to cure
the monocyte deficiency in oplop mice.
By contrast, cure of osteopetrosis and development of red
marrow in the long bones of oplop mice injected with rhM-
CSF once a day for 14 d was readily noticeable by macro-
scopic observation. In the long bones ofuninjected oplop mice,
development of the bone marrow cavity was prevented by
an excessive amount of bone trabeculae, and osteoclasts were
very rarely detected (Fig. 1 a) (1, 2, 4). In the bones of rhM-
CSF-injected oplop mice, however, the bone trabeculae in the
diaphysis were mostly replaced by bone marrow showing ac-
tive hemopoiesis. Furthermore, many osteoclasts were ob-
served on the surface of bone trabeculae in the metaphyseal
region (Fig. 1 b). No obvious abnormality was found in these
osteoclasts (Figs. 1, b and c), except that the cells tended to
be smaller in size and to contain a smaller number of nuclei
than the osteoclasts found in normal mice; whereas the os-
teoclasts in op/op mice have been reported to have an abnormal
cytoplasmic distribution ofacid phosphatase, toluidine blue-
positive and electron-dense cytoplasmic inclusions, and hyper-
trophy of clear zones and ruffled borders (1, 2). TRACP-
positive mononucleated cells were found in the bone marrow
cavity ofthe rhM-CSF-injected oplop mice (Fig. 1 b), consis-
tent with the finding of WiktorJedrzejczak et al. (6) that
TRACP-positive cells were detected in the bone marrow of
oplop mice implanted with diffusion chambers containing
L-929 cells. These observations demonstrate that a single in-
jection of rhM-CSF once a day for 14 d is sufficient to cure
the osteoclast deficiency in the long bones of op/op mice.
Failure of tooth eruption due to reduced bone resorption
is a common feature of mammalian osteopetrotic mutants.
As shown in Fig. 2 a, the molar teeth ofuninjected 25-d-old
op/op mice remained within mandible. The tooth germs were
All mice were killed at 25 d after birth. Neu, neutrophils; Eo, eosinophils; Lym, lymphocytes; Mono, monocytes; Ebl, erythroblasts .
' 5 ug of M-CSF was subcutaneously injected once to three times a day for 14 d.
t 200 cells were counted in each sample.
Table 1 .
Mouse
number
Hematological
Genotype
Parameters ofPeripheral Blood
No. of rhM-CSF
injections/d'
of Uninjected and M-CSF-injected
No. of nucleated
cells Neu
op/op Mice and Uninjected Normal
Differential counntt
Eo Lym Mono
Littermates
Ebl
10-3/,ul q
1 op/op - 5 .7 28 1 67 0 4
2 op/op - 6 .3 34 0 64 0 2
3 op/op 1 7 .2 21 0 79 0 0
4 op/op 1 7 .6 30 0 70 0 0
5 op/op 2 6 .3 14 8 70 8 1
6 op/op 3 6 .0 20 0 75 4 1
7 op/op 3 4.2 34 2 57 6 1
8 +/? - 6 .3 7 1 90 2 0
9 +/? - 12 .0 14 0 85 1 0Table 2 .
￿
Hematological Parameters of Spleen of Uninjected and M-CSF-injected op/op Mice and Uninfected Normal Littermates
Mice used in this experiment and in Table 1 were the same .
Abbreviations used in this Table are the same as those used in Table 1.
200 cells were counted in each sample .
completely ankylosed to bone trabeculae, andthe periodontal
ligament failed to develop . TRACP-positive cells were hardly
detectable in the mandibles. In contrast, in the mandibles
of theoplop mice injected with rhM-CSFonce aday for 14 d,
themucous membrane covering the second andthird molars
was broken down in places, and the crown of these molars
emerged through these perforations into the oral cavity (Fig.
Figure 1.
￿
Micrographs ofproximal tibias. Theproximal epiphyseal plate
is at the left in a and b . (a) TRACP-stained longitudinal section from
an uninfected op/op mouse. Large amount ofbone trabeculae and reduced
marrow space are noted.No TRACP-positive cells are found in this micro-
graph (x100). (b) TRACP-stained longitudinal section from an rhM-CSF-
injected op/opmouse. A large part ofbone trabeculae isreplaced by marrow
cavity, and a considerable number ofTRACP-positive osteoclasts (arrows)
are arranged along the surface of remaining bone trabeculae. TRACP-
positive mononucleated cells (arrowheads) are found in the marrow cavity
(x 100) . (c) Electron micrograph of tibial tissue from an rhM-CSF-injected
op/op mouse shows a giant cell displaying cytological characteristics of a
typical osteoclast, such as well-developed ruffled border, clear zone, and
lysosomal structures (x2,000) .
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2b) . Osteoclasts were detected on the surface ofalveolar bone,
and the roots and periodontal ligament of the molars had
apparently formed normally. These observations demonstrate
that an injection ofrhM-CSF once a day for 14 d restored
thedevelopment of molar tooth germs in oplop mice and led
to tooth eruption as a consequence of the recovery of bone
resorption .
On the inner surface o£ calvariae of oplop mice injected
with rhM-CSF two or three times a day for 14 d, we found
more osteoclasts than in age-matched + /? mice, and their
distribution wassimilar to that in + /? mice (datanot shown) .
Figure 2 .
￿
Toluidine blue-stained bucco-lingual sections of mandibles.
(a) Second molar of an uninjected op/op mouse is completely embedded
in the mandible, and its root is severely distorted (01) . (b) Toothcrown
of second molar of an rhM-CSF-injected op/op mouse has emerged into
oral cavity, and its root and periodontal ligament appear to be developing
normally (x31) .
Mouse
number Genotype
No. of rhM-CSF
injections/d
No . of nucleate
cells/spleen Neu Eo
Differential
L
counts'
Mono Ebl
x 10-8
1 op/op - 1.0 9 3 13 0 75
2 op/op - 1 .4 5 0 24 2 69
3 op/op 1 0.96 6 2 13 1 78
4 op/op 1 1.1 8 1 11 1 79
5 op/op 2 0.57 4 1 16 1 78
6 op/op 3 1.9 8 0 18 2 72
7 op/op 3 0.90 20 1 24 3 52
8 +/? - 1.1 6 0 26 2 66
9 +/? - 1.9 5 1 22 0 72Ourpresent study demonstrates that the deficiency in os-
teoclasts and monocytes in op/op mice is caused by the ab-
sence of functional M-CSF. Interestingly, osteoclasts in dif-
ferent bones and monocytes in peripheral blood showed
different responsiveness to therhM-CSF injections. Osteoclasts
appearing in response to the rhM-CSF injections showed a
distribution similar to that observed in normal mice and ac-
tively participated in physiological bone remodeling. These
observations strongly suggest that M-CSF plays an essential
role in the differentiation of osteoclasts and monocyte/mac-
rophages under physiological conditions. Since our present
experimental system does notallowus to further analyzethe
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precise role ofM-CSF in osteoclast andmacrophage differen-
tiation, and since some stromalcell lines derived from new-
born mouse calvaria or adult mouse bone marrow can sup-
port osteoclast differentiation (15), we have recently established
stromal cell lines from newborn oplop mouse calvariae. We
foundthat some of the cell lines can support the differentia-
tion of macrophages and osteoclasts only when M-CSF is
exogenously supplied (manuscript in preparation), confirming
our presentresults. Availability of the M-CSF-deficient mice
and stromalcell lines derivedfrom them will provideaunique
opportunity to clarify the physiological role of M-CSF.
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